Catalyst Biosciences Inc. (CBIO)
$18.38
$0.81
(4.58%)
As on 11-Jun-2026 15:43EDT
Market cap
$496 Mln
Revenue (TTM)
$42 Mln
P/E Ratio
--
P/B Ratio
2.8
Div. Yield
0 %
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
$0 Mln
-
ROE
-1.6 %
-
ROCE
-- %
-
Industry P/E
--
-
EV/EBITDA
0
-
Debt to Equity
0
-
Book Value
$--
-
EPS
$-16.9
-
Face value
--
-
Shares outstanding
27,571,935
10 Years Aggregate
CFO
$-376.69 Mln
EBITDA
$-414.33 Mln
Net Profit
$-367.22 Mln
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Catalyst Biosciences (CBIO)
| 54.9 | -2.1 | 46.4 | -- | 75.5 | 44.3 | 0.5 |
|
BSE Sensex
| -12.8 | -4.5 | -5.6 | -10.4 | 5.6 | 7.1 | 10.7 |
|
S&P Small-Cap 600#
| -5.8 | -5.3 | -13.7 | -6.3 | 5.3 | 3.0 | 5.5 |
|
Company
|
2022
|
2021
|
2020
|
2019
|
2018
|
2017
|
2016
|
|---|---|---|---|---|---|---|---|
|
Catalyst Biosciences (CBIO)
| 121.5 | -85.6 | -7.3 | -13.7 | -42.0 | 39.9 | -79.2 |
|
S&P Small-Cap 600
| -17.4 | 25.3 | 9.6 | 20.9 | -9.7 | 11.7 | 24.7 |
|
BSE Sensex
| 4.4 | 22.0 | 15.8 | 14.4 | 5.9 | 27.9 | 1.9 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price ($) | Market Cap ($ Mln) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Catalyst Biosciences (CBIO)
|
18.4 | 496.4 | 42.5 | -162.1 | -374.6 | -107.9 | -- | 2.8 |
| 291.6 | 40,461.0 | 4,286.9 | 577.2 | 9.8 | 88.2 | 76.3 | 37.6 | |
| 217.5 | 13,001.6 | 867.5 | 506.6 | -2.8 | -- | 23.9 | 23.8 | |
| 53.9 | 13,246.4 | 2,375.5 | 833.4 | 40.8 | 40.7 | 17.5 | 6.8 | |
| 179.7 | 30,617.8 | 16,632.0 | 1,385.0 | 14.1 | 22.3 | 22.8 | 5.0 | |
| 470.0 | 11,227.7 | 1,132.5 | -309.4 | -25.5 | -52.9 | -- | 20.9 | |
| 475.5 | 12,973.2 | 2,678.3 | 460.4 | 21.1 | 103.2 | 28.6 | 21.9 | |
| 614.1 | 66,620.0 | 14,919.6 | 4,423.4 | 34.9 | 14.2 | 15.5 | 2.1 | |
| 548.2 | 23,340.2 | 3,169.8 | 1,287.4 | 51.4 | 20.6 | 20.3 | 4.0 | |
| 445.2 | 113,407.9 | 12,255.1 | 4,338.3 | 31.7 | 23.7 | 26.5 | 5.9 |
Shareholding Pattern
View DetailsAbout Catalyst Biosciences (CBIO)
Crescent Biopharma, Inc., a biotechnology company, researches and develops cancer therapy candidates in the United States. Its pipeline includes CR-001, which is in Phase 3 clinical trial, a proprietary anti-PD-1/anti-VEGF bispecific antibody to... treat solid tumors; and CR-002, and CR-003. The company has a strategic partnership with Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. for the development and commercialization of oncology therapeutics. The company was formerly known as GlycoMimetics, Inc. The company was founded in 2024 and is headquartered in Waltham, Massachusetts. Read more
-
Pres, CEO & Director
Dr. Nassim Usman Ph.D.
-
Pres, CEO & Director
Dr. Nassim Usman Ph.D.
-
Headquarters
Waltham, MA
-
Website
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
FAQs for Catalyst Biosciences (CBIO)
What is the current share price of Catalyst Biosciences Inc (CBIO) Today?
The share price of Catalyst Biosciences Inc (CBIO) is $18.38 (NASDAQ) as of 11-Jun-2026 15:43 EDT. Catalyst Biosciences Inc (CBIO) has given a return of 75.48% in the last 3 years.
What is the current PB & PE ratio of Catalyst Biosciences Inc (CBIO)?
Since, TTM earnings of Catalyst Biosciences Inc (CBIO) is negative, P/E ratio is not available.
The P/B ratio of Catalyst Biosciences Inc (CBIO) is 2.83 times as on 05-Jun-2026, a 30 discount to its peers’ median range of 4.07 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
-0.77
|
0.58
|
|
2024
|
--
|
--
|
|
2023
|
--
|
--
|
|
2022
|
-0.01
|
0.02
|
|
2021
|
0.00
|
0.00
|
What is the 52 Week High and Low of Catalyst Biosciences Inc (CBIO)?
The 52-week high and low of Catalyst Biosciences Inc (CBIO) are Rs 27.41 and Rs 8.72 as of 12-Jun-2026.
What is the market cap of Catalyst Biosciences Inc (CBIO)?
Catalyst Biosciences Inc (CBIO) has a market capitalisation of $ 496 Mln as on 05-Jun-2026. As per SEBI classification, it is a Small Cap company.
Should I invest in Catalyst Biosciences Inc (CBIO)?
Before investing in Catalyst Biosciences Inc (CBIO), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.